Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1α

Circulation Research

Volumn 93, Issue 6, 2003, Pages 515-522

  Schaub, Friedemann J ^a   Liles, W Conrad ^a   Ferri, Nicola ^a   Sayson, Kirsten ^a   Seifert, Ronald A ^a   Bowen Pope, Daniel F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apoptosis; Calpain; Inflammation; Interleukin; Monocyte chemoattractant protein 1

Indexed keywords

CALPAIN; CASPASE 8; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; RETROVIRUS VECTOR; RNA; RNA 18S; UNCLASSIFIED DRUG; CARRIER PROTEIN; CASPASE; CYCLOHEXIMIDE; FADD PROTEIN, HUMAN; FAS LIGAND; FASLG PROTEIN, HUMAN; INTERLEUKIN 1; MEMBRANE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CALPAIN; CARRIER PROTEINS; CASPASES; CELLS, CULTURED; CHEMOKINE CCL2; CYCLOHEXIMIDE; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH, VASCULAR; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0141608940     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000093205.42313.7C     Document Type: Article

References (40)

1. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma. Am J Pathol. 1995;147:251-266.
2. Han DK, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
3. Schaub FJ, Han DK, Conrad Liles W, Adams LD, Coats SA, Ramachandran RK, Seifert RA, Schwartz SM, Bowen-Pope DF. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med. 2000;6:790-796.
4. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;97:2307-2315.
5. Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, Scheurich P. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J Biol Chem. 2000;275:24357-24366.
6. Hu WH, Johnson H, Shu HB. Activation of NF-κB by FADD, Casper, and caspase-8. J Biol Chem. 2000;275:10838-10844.
7. Moser R, Schleiffenbaum B, Groscurth P, Fehr J. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest. 1989;83:444-455.
8. Rectenwald JE, Moldawer LL, Huber TS, Seeger JM, Ozaki CK. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation. 2000;102:1697-1702.
9. Wang JM, Sica A, Peri G, Walter S, Padura IM, Libby P, Ceska M, Lindley I, Colotta F, Mantovani A. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb. 1991;11:1166-1174.
10. Loppnow H, Libby P. Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. Exp Cell Res. 1992;198:283-290.
11. Kiener PA, Davis PM, Starling GC, Mehlin C, Klebanoff SJ, Ledbetter JA, Liles WC. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J Exp Med. 1997;185:1511-1516.
12. Chinnaiyan AM, O'Rouke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995;81:505-512.
13. Kinoshita S, Su L, Amano M, Timmerman LA, Kaneshima H, Nolan GP. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity. 1997;6:235-244.
14. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
15. Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 1997;89:1067-1076.
16. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A. 1991;88:8485-8489.
17. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, Suda T. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med. 1998;4:1287-1292.
18. Kobayashi Y, Yamamoto K, Saido T, Kawasaki H, Oppenheim JJ, Matsushima K. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1α. Proc Natl Acad Sci U S A. 1990;87:5548-5552.
19. Kavita U, Mizel SB. Differential sensitivity of interleukin-1α and -β precursor proteins to cleavage by calpain, a calcium-dependent protease. J Biol Chem. 1995;270:27758-27765.
20. Glading A, Chang P, Lauffenburger DA, Wells A. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem. 2000;275:2390-2398.
21. Wolf BB, Goldstein JC, Stennicke HR, Beere H, Amarante-Mendes GP, Salvesen GS, Green DR. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood. 1999;94:1683-1692.
22. Ruiz-Vela A, Gonzalez de Buitrago G, Martinez AC. Implication of calpain in caspase activation during B cell clonal deletion. EMBO J. 1999;18:4988-4998.
23. Squier MK, Sehnert AJ. Sellins KS, Malkinson AM, Takano E, Cohen JJ. Calpain and calpastatin regulate neutrophil apoptosis. J Cell Physiol. 1999;178:311-319.
24. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095-2147.
25. Tarantini F, Micucci I, Bellum S, Landriscina M, Garfinkel S, Prudovsky I, Maciag T. The precursor but not the mature form of ILα blocks the release of FGF1 in response to heat shock. J Biol Chem. 2001;276:5147-5151.
26. Mandinov L, Mandinova A, Kyurkchiev S, Kyurkchiev D, Kehayov I, Kolev V, Soldi R, Bagala C, De Muinck ED, Lindner V, Post MJ, Simons M, Bellum S, Prudovsky I, Maciag T. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci USA. 2003;100:6700-6705.
27. Schonbeck U, Herzberg M, Petersen A, Wohlenberg C, Gerdes J, Flad HD, Loppnow H. Human vascular smooth muscle cells express interleukin-1β -converting enzyme (ICE), but inhibit processing of the interleukin-1α precursor by ICE. J Exp Med. 1997;185:1287-1294.
28. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 1997;95:981-987.
29. Maier JA, Statuto M, Ragnoiti G. Endogenous interleukin 1α must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol. 1994;14:1845-1851.
30. Solari R, Smithers N, Kennard N, Ray K, Grenfell S. Receptor mediated endocytosis and intracellular fate of interleukin 1. Biochem Pharmacol. 1994;47:93-101.
31. McMahon GA, Garfinkel S, Prudovsky I, Hu X, Maciag T. Intracellular precursor interleukin (IL)-1α, but not mature IL-1α, is able to regulate human endothelial cell migration in vitro. J Biol Chem. 1997;272:28202-28205.
32. Pollock AS, Turck J, Lovett DH. The prodomain of interleukin 1α interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells. FASEB J. 2003;17:203-213.
33. Rubartelli A, Cozzolino F, Talio M, Sitia R. A novel secretory pathway for interleukin-1 β, a protein lacking a signal sequence. EMBO J. 1990;9:1503-1510.
34. Siders WM, Klimovitz JC, Mizel SB. Characterization of the structural requirements and cell type specificity of IL-1 α and IL-1 β secretion. J Biol Chem. 1993;268:22170-22174.
35. Howard AD, Kostura MJ, Thornberry N, Ding GJ, Limjuco G, Weidner J, Salley JP, Hogquist KA, Chaplin DD, Mumford RA, et al. IL-1-Converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-kDa IL-1α. J Immunol. 1991;147:2964-2969.
36. Chua BT, Guo K, Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem. 2000;275:5131-5135.
37. Goll DE, Thompson VF, Taylor RG, Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays. 1992;14:549-556.
38. 2+-dependent neutral proteinase of human erythrocytes. Biochem Biophys Res Commun. 1985;129:389-395.
39. Saido TC, Nagao S, Shiramine M, Tsukaguchi M, Yoshizawa T, Sorimachi H, Ito H, Tsuchiya T, Kawashima S, Suzuki K. Distinct kinetics of subunit autolysis in mammalian m-calpain activation. FEBS Lett. 1994;346:263-267.
40. Wang KK, Posmantur R, Nadimpalli R, Nath R, Mohan P, Nixon RA, Talanian RV, Keegan M, Herzog L, Allen H. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys. 1998;356:187-196.